title: Testosterone Replacement Therapy and the Cardiovascular System.
abstract: As testosterone replacement therapy (TRT) has emerged as a commonly prescribed therapy for symptomatic low testosterone, conflicting data have been reported in terms of both its efficacy and potential adverse outcomes. One of the most controversial associations has been that of TRT and cardiovascular morbidity and mortality. This review briefly provides background on the history of TRT, the indications for TRT, and the data behind TRT for symptomatic low testosterone. It then specifically delves into the rather limited data for cardiovascular outcomes of those with low endogenous testosterone and those who receive TRT. The available body of literature strongly suggests that more work, by way of clinical trials, needs to be done to better understand the impact of testosterone and TRT on the cardiovascular system.
authors.affiliation: Division of Cardiology, Stanford University Medical Center, 300 Pasteur Drive, H2155, Stanford, CA, 94305, USA. snaderi@stanford.edu.
authors.forename: Sahar
authors.initials: S
authors.lastname: Naderi
mesh_terms: D000728:Androgens / Q000493:pharmacokinetics / Q000627:therapeutic use*; D002319:Cardiovascular System / Q000187:drug effects*; D020249:Hormone Replacement Therapy; D006801:Humans; D013739:Testosterone / Q000493:pharmacokinetics / Q000627:therapeutic use*
chemical_list: D000728:Androgens; D013739:Testosterone
keywords: Androgens; Cardiovascular disease; Male hormone therapy; Testosterone